Promising scientific data open up new therapeutic combination options for the epigenetic anti-cancer compound resminostat.
by eazee-designstudio
NEUWAY Receives €2.95 Million BMBF Grant for Advancing CNS Drug Delivery Platform. CLICK FOR MORE.
invendo medical Announces FDA Clearance of the invendoscopy E200 System –Including the First and Only Sterile, Single-use Endoscope For Colonoscopies
New worldwide, exclusive license agreement provides broad access to Institut Pasteur's virus vector technology – Zika vaccine development progressing with high priority
Symetis has announced the acquisition of Middle Peak Medical. Wellington Partners led the Series A investment into Middle Peak in 2013.
Symetis has announced that it has agreed to be acquired by Boston Scientific in an all cash, up-front payment.
